Training, guideline access and knowledge of antiretroviral interactions: Is the South African private sector being left behind?
Background. South Africa (SA) has the largest antiretroviral therapy programme in the world. While the majority of the country accesses healthcare in the public sector, 15.2% access private healthcare. In 2019, dolutegravir was introduced as first-line treatment for HIV. Dolutegravir has clinically...
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
South African Medical Association
2022-10-01
|
| Серии: | South African Medical Journal |
| Предметы: | |
| Online-ссылка: | https://samajournals.co.za/index.php/samj/article/view/263 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|